Global Matrechs, Inc. Announces Licensing Agreement for Radiation Resistant Technology Targeting Environmental and Nuclear Waste Markets in the European Community, China and India.RIDGEFIELD, Conn. -- Global Matrechs, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :GMTH) http://www.globalmatrechs.com, a company with technologies in the nuclear, chemical and environmental sectors, reports it has entered into a licensing agreement with NUCON-RF, Inc.,("NUCON NUCON Nucleus Constant "), http://www.nucon-rf.com, a US Corporation with executive and operations offices in Moscow, to market NuCap(TM). The agreement gives NUCON-RF exclusive distribution in the Former Soviet Union and non-exclusive rights in the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community , China and India for NuCap(TM), a highly radiation- and corrosion-resistant technology. NUCON's expertise and focus is technical solutions for high-end environmental markets in the Former Soviet Union, Europe & Asia. NUCON has identified markets and demand for the cleaning up of nuclear waste and other markets for NuCap(TM) including the Chernobyl Shelter. The strategic alliances of NUCON-RF include ROSENERGOATOM ("ROSATOM"), the operating utility of all Russia's nuclear power plants and ATOMSTROYEXPORT ("ASE (Adaptive Server Enterprise) A relational DBMS from Sybase that runs on Windows NT/2000, Linux and a variety of Unix platforms. ASE is a comprehensive and robust data management product with a long history dating back to the late 1980s. "). ASE was established by the Ministry of the Russian Federation Russian Federation: see Russia. for Atomic Energy atomic energy: see nuclear energy. , to promote the export of Russian-made products for nuclear power projects abroad. Under the terms, Global Matrechs, Inc. retains ownership and controls the worldwide exclusive proprietary rights to NuCap(TM), with manufacturing via Dow Corning Dow Corning is a multinational corporation headquartered in Midland, Michigan, USA. Dow Corning specializes in silicon and silicone-based technology, offering more than 7,000 products and services. Dow Corning is equally owned by The Dow Chemical Company and Corning, Inc. . NUCON-RF has the sub-license rights to market, sell and distribute NuCap(TM) into the following territories; Russian Federation on an exclusive basis, European Union, China and India on a non-exclusive basis. According to CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Michael Sheppard, "We have been working on this agreement for 18 months in order to execute delivery of NuCap(TM) into new foreign markets. We are thrilled to be associated with NUCON-RF and foresee the market penetration that was expected for the technology in the Eastern European markets years ago, to finally come to fruition." NuCap(TM) is engineered for use in a wide variety of applications in low to high level radiation and other environmentally challenging settings. NuCap(TM) applications range from in-situ stabilization, D & D, containment and encapsulation (1) In object technology, the creation of self-contained modules that contain both the data and the processing. See object-oriented programming. (2) The transmission of one network protocol within another. to transportation and final storage and disposal. NuCap(TM) can also assist in resolving the special challenges faced by operating reactors in nuclear power plants and research facilities, uranium/thorium and other mining venues, nuclear medicine and the chemical industry. About NUCON_RF http://www.nucon-rf.com/ (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). :SFDE SFDE Stochastic Functional-Differential Equation SFDE San Francisco Department of the Environment .PK) Nucon has the capability to provide product, technological and engineering support for environmental and radioactive waste challenges including, compliance, shielding, transport and storage requirements for a broad range of radioactive and toxic wastes. About Global Matrechs: www.globalmatrechs.com Global Matrechs has operated its licensed technologies business since 2004. Global Matrechs seeks to convert the licenses it has acquired in emerging technologies in the nuclear energy, environmental and chemical industries into manufactured products primarily through sub-licenses of those technologies to manufacturers. "Forward-Looking Statements" Investors are cautioned that certain statements contained in this document, as well as other statements in periodic press releases and some oral statements of Global Matrechs, Inc. officials during presentations, are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, or which include words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", "hopes," "seeks," or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates Growth Rates The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures. Notes: Remember, historically high growth rates don't always mean a high rate of growth looking into the future. ), ongoing business strategies or prospects, and possible future actions, which may be provided by management, are also forward-looking statements as defined by the Act. Some of the factors that could significantly impact these forward-looking statements in this press release include, but are not limited to: insufficient cash flow to continue to fund the development and marketing of the Company's products and technologies; the failure of the Company's products and technologies to become commercially marketable; the loss of key personnel; changes in financial markets and general economic conditions; and, disputes as to the Company's intellectual property rights, including the Company's rights to the technologies that it licenses from Eurotech, Ltd. Forward-looking statements are based upon current expectations and projections about future events and are subject to risks, uncertainties, and assumptions about Global Matrechs, its licenses, products, economic and market factors and the sectors in which Global Matrechs does business, among other things. These statements are not guarantees of future performance and Global Matrechs has no specific intention to update these statements. More detailed information about those factors is contained in Global Matrechs's filings with the Securities and Exchange Commission. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion